{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:04:09Z","timestamp":1761156249206},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,2,6]],"date-time":"2017-02-06T00:00:00Z","timestamp":1486339200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"none"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s00066-017-1103-3","type":"journal-article","created":{"date-parts":[[2017,2,6]],"date-time":"2017-02-06T10:16:12Z","timestamp":1486376172000},"page":"385-391","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Radical hypo-fractionated radiotherapy with volumetric modulated arc therapy in lung cancer"],"prefix":"10.1007","volume":"193","author":[{"given":"D.","family":"Franceschini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"De Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Cozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Navarria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Clerici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Franzese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Comito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Iftode","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"D\u2019Agostino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sorsetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,6]]},"reference":[{"key":"1103_CR1","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3322\/caac.20073","volume":"60","author":"A Jemal","year":"2010","unstructured":"Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics. CA Cancer J Clin 60:277\u2013300","journal-title":"CA Cancer J Clin"},{"key":"1103_CR2","doi-asserted-by":"publisher","first-page":"5570","DOI":"10.1200\/JCO.2007.12.5435","volume":"25","author":"TK Owonikoko","year":"2007","unstructured":"Owonikoko TK, Ragin CC, Belani CP et\u00a0al (2007) Lung cancer in elderly patients: An analysis of the surveillance, epidemiology, and end results database. J\u00a0Clin Oncol 25:5570\u20135577","journal-title":"J Clin Oncol"},{"key":"1103_CR3","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1200\/JCO.2009.26.2543","volume":"28","author":"A Aup\u00e9rin","year":"2010","unstructured":"Aup\u00e9rin A, Le P\u00e9choux C, Rolland E et al (2010) Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J\u00a0Clin Oncol 28:2181\u20132190","journal-title":"J Clin Oncol"},{"key":"1103_CR4","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1016\/j.ejca.2014.07.009","volume":"50","author":"J Maguire","year":"2014","unstructured":"Maguire J, Khan I, McMenemin R, O\u2019Rourke N, McNee S, Kelly V, Peedell C, Snee MSOCCAR (2014) A randomised phase II trial comparing sequential versus concurrent chemotherapy and radical hypofractionated radiotherapy in patients with inoperable stage III Non-Small Cell Lung Cancer and good performance status. Eur J Cancer 50:2939\u20132949","journal-title":"Eur J Cancer"},{"key":"1103_CR5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1093\/annonc\/mdn559","volume":"20","author":"D Ruysscher De","year":"2009","unstructured":"De Ruysscher D, Botterweck A, Dirx M et al (2009) Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: A\u00a0prospective, population-based study. Ann Oncol 20:98\u2013102","journal-title":"Ann Oncol"},{"key":"1103_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0169-5002(99)00019-7","volume":"24","author":"MK Martel","year":"1999","unstructured":"Martel MK, Ten Haken RK, Hazuka MB et al (1999) Estimation of tumor control probability model parameters from 3\u2011D dose distributions of non-small cell lung cancer patients. Lung Cancer 24:31\u201337","journal-title":"Lung Cancer"},{"key":"1103_CR7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/jnci\/83.6.417","volume":"83","author":"T Chevalier Le","year":"1991","unstructured":"Le Chevalier T, Arriagada R, Quoix E et al (1991) Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small cell lung cancer: First analysis of a\u00a0randomized trial in 353 patients. J\u00a0Natl Cancer Inst 83:417\u2013423","journal-title":"J Natl Cancer Inst"},{"key":"1103_CR8","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1097\/JTO.0b013e3182429682","volume":"7","author":"M Machtay","year":"2012","unstructured":"Machtay M, Paulus R, Moughan J et al (2012) Defining local-regional control and its importance in locally advanced non-small cell lung carcinoma: A\u00a0Radiation Therapy Oncology Group analysis. J\u00a0Thorac Oncol 7:716\u2013722","journal-title":"J Thorac Oncol"},{"key":"1103_CR9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"JD Bradley","year":"2015","unstructured":"Bradley JD, Paulus R, Komaki R et al (2015) Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): A\u00a0randomised, two-by-two factorial phase 3 study. Lancet Oncol 16:187\u2013199","journal-title":"Lancet Oncol"},{"key":"1103_CR10","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S0360-3016(99)00364-8","volume":"46","author":"JF Fowler","year":"2000","unstructured":"Fowler JF, Chappell R (2000) Nonsmall cell lung tumors repopulate rapidly during radiation therapy. Int J Radiat Oncol Biol Phys 46:516\u2013517","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1103_CR11","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1200\/JCO.2012.41.6677","volume":"30","author":"A Mauguen","year":"2012","unstructured":"Mauguen A, Le Pechoux C, Saunders MI et al (2012) Hyperfractionated or accelerated radiotherapy in lung cancer: An individual patient data meta-analysis. J\u00a0Clin Oncol 30:2788\u20132797","journal-title":"J Clin Oncol"},{"key":"1103_CR12","doi-asserted-by":"publisher","unstructured":"Scorsetti M, Clerici E, Navarria P, D\u2019Agostino G, Piergallini L, De Rose F, Ascolese A, Tozzi a, Iftode C, Villa E, Comito T, Franzese C, Mancosu P, Tomatis S, Cozzi L (2015) The role of stereotactic body radiation therapy (SBRT) in the treatment of  oligometastatic disease in the elderly. Br J Radiol 88:20150111","DOI":"10.1259\/bjr.20150111"},{"key":"1103_CR13","doi-asserted-by":"publisher","unstructured":"Scorsetti M, Navarria P, De Rose F, Ascolese A, Cletici E, Franzese C, Lobefalo F, Reggiori G, Mancosu P, Tomatis S, Fogliata A, Cozzi L (2014) Outcome and toxicity profiles in the treatment of locally advanced lung cancer with volumetric modulated arc therapy. Cancer Res Clin Oncol 140:1937\u201345","DOI":"10.1007\/s00432-014-1739-7"},{"key":"1103_CR14","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.ejim.2014.10.024","volume":"25","author":"P Froesch","year":"2014","unstructured":"Froesch P, Martucci F, Gy\u00f6rik S, Dutly AE, Cafarotti S (2014) Management of non-small cell lung cancer in the elderly. Eur J Intern Med 25:888\u2013894","journal-title":"Eur. J. Intern. Med."},{"key":"1103_CR15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.critrevonc.2005.06.003","volume":"55","author":"M Extermann","year":"2005","unstructured":"Extermann M, Aapro M, Bernabei R, Cohen HJ, Droz JP, Lichtman S et\u00a0al (2005) Task Force on CGA of the International Society of Geriatric Oncology. Use of comprehensive geriatric assessment in older cancer patients: Recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 55:241\u2013252","journal-title":"Crit Rev Oncol Hematol"},{"key":"1103_CR16","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1093\/jnci\/88.17.1210","volume":"88","author":"RO Dillman","year":"1996","unstructured":"Dillman RO, Herndon J, Seagren SL et al (1996) Improved survival in stage III non-small-cell lung cancer: Seven-year folow-up of cancer and leukemia group B (CALGB) 8433 trial. J\u00a0Natl Cancer Inst 88:1210\u20131215","journal-title":"J Natl Cancer Inst"},{"key":"1103_CR17","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0360-3016(97)00365-9","volume":"39","author":"R Komaki","year":"1997","unstructured":"Komaki R, Scott CB, Sause WT et al (1997) Induction cisplatin\/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: Failure patterns by cell type in RTOG 88-08\/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys 39:537\u2013544","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1103_CR18","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1023\/B:QURE.0000031335.02254.3b","volume":"13","author":"DW Bruner","year":"2004","unstructured":"Bruner DW, Movsas B, Konski A et\u00a0al (2004) Outcomes research in cancer clinical trial cooperative groups: The RTOG model. Qual Life Res 13:1025\u20131041","journal-title":"Qual Life Res"},{"key":"1103_CR19","doi-asserted-by":"publisher","unstructured":"Kale MS, Mhango G, Gomez JE, Sigel K, Smith CB, Bonomi M, Wisnivesky JP (2015) Treatment toxicity in elderly patients with advanced non-small cell lung cancer. Am J Clin Oncol 25784564. doi:\n                        10.1097\/COC.0000000000000188","DOI":"10.1097\/COC.0000000000000188"},{"key":"1103_CR20","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1016\/j.ejca.2014.07.009","volume":"50","author":"J Maguire","year":"2014","unstructured":"Maguire J, Khan I, McNememin R, O\u2019Rourke N et\u00a0al (2014) SOCCAR: A randomized phase II trial comparing sequential versus concurrent chemotherapy and radical hypofractionated radiotherapy in patients with inoperable stage III non small cell lung cancer and good performance status. Eur J Cancer 50:2939\u20132949","journal-title":"Eur J Cancer"},{"key":"1103_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cllc.2014.08.002","volume":"16","author":"TS Kaster","year":"2015","unstructured":"Kaster TS, Yaremko B, Palma DA, Rodrigues GB (2015) Radical-intent Hypofractionated radiotherapy for locally advanced nonesmall-cell lung cancer: A systematic review of the literature. Clin Lung Cancer 16:71\u201379","journal-title":"Clin Lung Cancer"},{"key":"1103_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.radonc.2011.02.014","volume":"99","author":"M Partridge","year":"2011","unstructured":"Partridge M, Ramos M, Sardaro A, Brada M (2011) Dose escalation for non small cell lung cancer: analysis and modelling of published literature. Radiother Oncol 99:6\u201311","journal-title":"Radiother Oncol"},{"key":"1103_CR23","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/S0360-3016(99)00130-3","volume":"44","author":"LN Nguyen","year":"1999","unstructured":"Nguyen LN, Komaki R, Allen P, Schea RA, Milas L (1999) Effectiveness of accelerated radiotherapy for patients with inoperable nonesmall cell lung cancer (NSCLC) and borderline prognostic factors without distant metastasis: A\u00a0retrospective review. Int J Radiat Oncol Biol Phys 44:1053\u20131056","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1103_CR24","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0360-3016(00)00429-6","volume":"47","author":"LM Sun","year":"2000","unstructured":"Sun LM, Leung SW, Wang CJ et al (2000) Concomitant boost radiation therapy for inoperable nonesmall-cell lung cancer: Preliminary report of a\u00a0prospective randomized study. Int J Radiat Oncol Biol Phys 47:413\u2013418","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1103_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1748-717X-7-33","volume":"7","author":"A Amini","year":"2012","unstructured":"Amini A, Lin SH, Wei C, Allen P, Cox JD, Komaki R (2012) Accelerated hypofractionated radiation therapy compared to conventionally fractionated radiation therapy for the treatment of inoperable nonesmall cell lung cancer. Radiat Oncol 7:33","journal-title":"Radiat Oncol"},{"key":"1103_CR26","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s13014-015-0560-z","volume":"10","author":"JH Joo","year":"2015","unstructured":"Joo JH, Song SY, Kim SS, Jeong Y, Jeong SY, Choi W, Choi EK (2015) Definitive radiotherapy alone over 60\u202fGy for patients unfit for combined treatment to stage II-III non-small cell lung cancer: Retrospective analysis. Radiat Oncol 10:250. doi:\n                        10.1186\/s13014-015-0560-z","journal-title":"Radiat Oncol"},{"key":"1103_CR27","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.ijrobp.2008.06.1935","volume":"73","author":"L Wang","year":"2009","unstructured":"Wang L, Correa CR, Zhao L, Hayman J, Kalemkerian GP, Lyons S et al (2009) The effect of radiation dose and chemotherapy on overall survival in 237 patients with Stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 73:1383\u20131390","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1103_CR28","doi-asserted-by":"publisher","first-page":"42534","DOI":"10.1016\/j.ijrobp.2010.09.004","volume":"82","author":"M Machtay","year":"2012","unstructured":"Machtay M, Bae K, Movsas B, Paulus R, Gore EM, Komaki R et\u00a0al (2012) Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non small cell lung carcinoma treated with chemoradiation: An analysis of the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 82:42534","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-017-1103-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-017-1103-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-017-1103-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T14:16:01Z","timestamp":1493129761000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-017-1103-3"}},"subtitle":["A retrospective study of elderly patients with stage\u00a0III disease"],"short-title":[],"issued":{"date-parts":[[2017,2,6]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["1103"],"URL":"https:\/\/doi.org\/10.1007\/s00066-017-1103-3","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,6]]}}}